Successful Treatment of Systemic Sclerosis-related Pericarditis with Mycophenolate Mofetil and Low-dose Prednisolone
-
- Higashioka Kazuhiko
- Department of Rheumatology, Aso Iizuka Hospital, Japan
-
- Migita Rioko
- Department of Rheumatology, Aso Iizuka Hospital, Japan
-
- Ota Toshiyuki
- Department of Rheumatology, Aso Iizuka Hospital, Japan
-
- Uchino Ayumi
- Department of Rheumatology, Aso Iizuka Hospital, Japan
-
- Niiro Hiroaki
- Department of Medical Education, Kyushu University Graduate School of Medical Sciences, Japan
Search this article
Description
<p>We herein report a case of systemic sclerosis (SSc)-related pericarditis successfully treated with mycophenolate mofetil (MMF) and low-dose prednisolone (PSL). The patient was a 72-year-old woman with anti-centromere antibody. Her clinical manifestations were Raynaud phenomenon, bilateral pleural effusion, pericardial effusion and skin tightness. Based on the findings of exudative pericardial effusion with the absence of pulmonary arterial hypertension from the results of the cardiac catheter and pericardiocentesis, she was diagnosed with SSc-related pericarditis and treated with PSL10 mg and MMF 1 g per day, leading to the complete resolution of pericarditis. These findings suggested that MMF and low-dose PSL were effective for SSc-related pericarditis. </p>
Journal
-
- Internal Medicine
-
Internal Medicine 61 (20), 3125-3130, 2022-10-15
The Japanese Society of Internal Medicine
